FONAR CORP(NASDAQ:FONR) stock Fundamental Analysis

Fundamental Rating

We assign a fundamental rating of 5 out of 10 to FONR. FONR was compared to 190 industry peers in the Health Care Equipment & Supplies industry. FONR has an excellent financial health rating, but there are some minor concerns on its profitability. FONR is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

FONR had positive earnings in the past year.

In the past year FONR had a positive cash flow from operations.

FONR had positive earnings in each of the past 5 years.

Each year in the past 5 years FONR had a positive operating cash flow.

1.2 Ratios

With a decent Return On Assets value of 3.52%, FONR is doing good in the industry, outperforming 78.42% of the companies in the same industry.

Looking at the Return On Equity, with a value of 4.31%, FONR is in the better half of the industry, outperforming 77.37% of the companies in the same industry.

FONR has a better Return On Invested Capital (4.66%) than 77.89% of its industry peers.

The Average Return On Invested Capital over the past 3 years for FONR is in line with the industry average of 7.83%.

		Industry Rank	Sector Rank
ROA	3.52%
ROE	4.31%
ROIC	4.66%

ROA(3y)4.96%

ROA(5y)4.84%

ROE(3y)6.44%

ROE(5y)6.47%

ROIC(3y)7.14%

ROIC(5y)7.07%

1.3 Margins

With an excellent Profit Margin value of 7.20%, FONR belongs to the best of the industry, outperforming 80.53% of the companies in the same industry.

In the last couple of years the Profit Margin of FONR has declined.

The Operating Margin of FONR (11.93%) is better than 78.95% of its industry peers.

FONR's Operating Margin has declined in the last couple of years.

FONR has a worse Gross Margin (41.48%) than 68.42% of its industry peers.

FONR's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	11.93%
PM (TTM)	7.2%
GM	41.48%

OM growth 3Y-5.46%

OM growth 5Y-8.71%

PM growth 3Y-3.38%

PM growth 5Y-10.22%

GM growth 3Y-3.21%

GM growth 5Y-2.4%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FONR is destroying value.

Compared to 1 year ago, FONR has less shares outstanding

FONR has about the same amout of shares outstanding than it did 5 years ago.

FONR has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.75 indicates that FONR is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Altman-Z score of FONR (2.75) is better than 65.79% of its industry peers.

FONR has a debt to FCF ratio of 0.07. This is a very positive value and a sign of high solvency as it would only need 0.07 years to pay back of all of its debts.

FONR has a better Debt to FCF ratio (0.07) than 94.21% of its industry peers.

A Debt/Equity ratio of 0.00 indicates that FONR is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.00, FONR is in the better half of the industry, outperforming 70.00% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.07
Altman-Z	2.75

ROIC/WACC0.52

WACC8.94%

2.3 Liquidity

A Current Ratio of 11.24 indicates that FONR has no problem at all paying its short term obligations.

Looking at the Current ratio, with a value of 11.24, FONR belongs to the top of the industry, outperforming 93.68% of the companies in the same industry.

FONR has a Quick Ratio of 11.01. This indicates that FONR is financially healthy and has no problem in meeting its short term obligations.

FONR has a better Quick ratio (11.01) than 94.74% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	11.24
Quick Ratio	11.01

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

FONR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.52%.

Measured over the past years, FONR shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.12% on average per year.

Looking at the last year, FONR shows a decrease in Revenue. The Revenue has decreased by -0.83% in the last year.

Measured over the past years, FONR shows a small growth in Revenue. The Revenue has been growing by 3.36% on average per year.

EPS 1Y (TTM)-38.52%

EPS 3Y1.78%

EPS 5Y-7.12%

EPS Q2Q%-46.78%

Revenue 1Y (TTM)-0.83%

Revenue growth 3Y4.6%

Revenue growth 5Y3.36%

Sales Q2Q%-1.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

FONR is valuated correctly with a Price/Earnings ratio of 13.17.

93.16% of the companies in the same industry are more expensive than FONR, based on the Price/Earnings ratio.

Compared to an average S&P500 Price/Earnings ratio of 29.35, FONR is valued rather cheaply.

		Industry Rank	Sector Rank
PE	13.17
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FONR indicates a rather cheap valuation: FONR is cheaper than 98.95% of the companies listed in the same industry.

FONR's Price/Free Cash Flow ratio is rather cheap when compared to the industry. FONR is cheaper than 96.84% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	10.98
EV/EBITDA	1.92

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

FONR does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

FONAR CORP

NASDAQ:FONR (3/7/2025, 8:27:34 PM)

14.09

-0.42 (-2.89%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)02-17 2025-02-17

Earnings (Next)05-13 2025-05-13

Inst Owners49.73%

Inst Owner Change0.44%

Ins Owners2.2%

Ins Owner Change0%

Market Cap89.19M

Analysts0

Price TargetN/A

Short Float %0.29%

Short Ratio1.3

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	13.17
Fwd PE	N/A
P/S	0.88
P/FCF	10.98
P/OCF	7.89
P/B	0.53
P/tB	0.55
EV/EBITDA	1.92

EPS(TTM)1.07

EY7.59%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)1.28

FCFY9.1%

OCF(TTM)1.79

OCFY12.67%

SpS16.05

BVpS26.83

TBVpS25.62

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	3.52%
ROE	4.31%
ROCE	6.19%
ROIC	4.66%
ROICexc	6.42%
ROICexgc	6.78%
OM	11.93%
PM (TTM)	7.2%
GM	41.48%
FCFM	7.99%

ROA(3y)4.96%

ROA(5y)4.84%

ROE(3y)6.44%

ROE(5y)6.47%

ROIC(3y)7.14%

ROIC(5y)7.07%

ROICexc(3y)9.85%

ROICexc(5y)9.62%

ROICexgc(3y)10.45%

ROICexgc(5y)10.24%

ROCE(3y)9.49%

ROCE(5y)9.41%

ROICexcg growth 3Y-5.28%

ROICexcg growth 5Y-14.37%

ROICexc growth 3Y-4.76%

ROICexc growth 5Y-13.51%

OM growth 3Y-5.46%

OM growth 5Y-8.71%

PM growth 3Y-3.38%

PM growth 5Y-10.22%

GM growth 3Y-3.21%

GM growth 5Y-2.4%

F-Score6

Asset Turnover0.49

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	0.07
Debt/EBITDA	0.02
Cap/Depr	47.9%
Cap/Sales	3.13%
Interest Coverage	367.29
Cash Conversion	60.23%
Profit Quality	111.04%
Current Ratio	11.24
Quick Ratio	11.01
Altman-Z	2.75

F-Score6

WACC8.94%

ROIC/WACC0.52

Cap/Depr(3y)68.94%

Cap/Depr(5y)98.58%

Cap/Sales(3y)3.32%

Cap/Sales(5y)4.6%

Profit Quality(3y)113.41%

Profit Quality(5y)133.25%

High Growth Momentum

Growth

EPS 1Y (TTM)-38.52%

EPS 3Y1.78%

EPS 5Y-7.12%

EPS Q2Q%-46.78%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-0.83%

Revenue growth 3Y4.6%

Revenue growth 5Y3.36%

Sales Q2Q%-1.72%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-33.05%

EBIT growth 3Y-1.11%

EBIT growth 5Y-5.64%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-28.96%

FCF growth 3Y-4.82%

FCF growth 5Y-3.64%

OCF growth 1Y-26.41%

OCF growth 3Y-9.62%

OCF growth 5Y-6.24%

FONAR CORP (FONR) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens